Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
R-EPOCH regimen
Introduction
Synonyms and keywords: Rituximab-Etoposide-Prednisone-Oncovin-Cyclophosphamide-Hydroxydaunorubicin regimen
Overview
Overview
R-EPOCH regimen refers to a regimen consisting of rituximab, etoposide, prednisone, vincristine (Oncovin), cyclophosphamide, and doxorubicin (hydroxydaunorubicin) used to treat Hodgkin’s lymphoma and HIV-associated lymphoma.[1][2]
Regimen
Regimen
RRituximab
EEtoposide
PPrednisone
OVincristine (Oncovin)
CCyclophosphamide
HDoxorubicin (Hydroxydaunorubicin)
Indications
Indications
References
References
- ↑ 1.0 1.1 Wilson WH, Dunleavy K, Pittaluga S, Hegde U, Grant N, Steinberg SM; et al. (2008). “Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers”. J Clin Oncol. 26 (16): 2717–24. doi:10.1200/JCO.2007.13.1391. PMC 2409217. PMID 18378569.
- ↑ 2.0 2.1 Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF; et al. (2010). “Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma”. Blood. 115 (15): 3008–16. doi:10.1182/blood-2009-08-231613. PMC 2858478. PMID 20023215.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]